Author:
Chang Mei H.,Guo Yi,Acbo Antoinette,Bao Hongkai,McSweeney Terrence,Vo Christopher A.,Nori Priya
Reference67 articles.
1. National Institutes of Health. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf. Accessed March 25, 2024.
2. Cabenuva (Cabotegravir and Rilpivirine) [Prescribing Information]. ViiV healthcare, Durham, NC; 2023.
3. Demonstration project of long-acting antiretroviral therapy in a diverse population of people with HIV;Gandhi;Ann Intern Med,2023
4. First demonstration project of long-acting injectable antiretroviral therapy for persons with and without detectable human immunodeficiency virus (HIV) viremia in an urban HIV clinic;Christopoulos;Clin Infect Dis,2023
5. 1582. Real-world use of long-acting cabotegravir + rilpivirine in the US: effectiveness in the first year;Sension;Open Forum Infect Dis,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献